Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Gelesis Holdings, Inc. (GLS)

5   0.3 (6.38%) 05-16 07:58
Open: 4.8 Pre. Close: 4.7
High: 5.18 Low: 4.77
Volume: 119,436 Market Cap: 362(M)
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.18 - 5.21 5.21 - 5.23
Low: 4.71 - 4.74 4.74 - 4.76
Close: 4.96 - 5 5 - 5.04

Technical analysis

as of: 2022-05-16 7:48:33 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.66     One year: 7.78
Support: Support1: 4.77    Support2: 4.19
Resistance: Resistance1: 5.71    Resistance2: 6.66
Pivot: 4.91
Moving Average: MA(5): 4.73     MA(20): 4.83
MA(100): 5.32     MA(250): 8.05
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 47.2     %D(3): 36.3
RSI: RSI(14): 52.5
52-week: High: 12.22  Low: 2.54
Average Vol(K): 3-Month: 355 (K)  10-Days: 88 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GLS ] has closed below upper band by 43.1%. Bollinger Bands are 52% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 16 May 2022
Toni Braxton Turns Her Glam On in Her Mercedes-Maybach GLS 600 4MATIC - autoevolution

Sat, 14 May 2022
Gelesis Holdings' (GLS) CEO Yishai Zohar on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha

Wed, 11 May 2022
VROOM WITH A VIEW: The Mercedes-Benz GLS 400d status warrior is a superb SUV - Daily Maverick

Wed, 11 May 2022
Olefin Block Copolymer (OBC) Market Size And Forecast | Dow Chemical, Polyone (GLS Corp) – Queen Anne and Mangolia News - Queen Anne and Mangolia News

Wed, 11 May 2022
Mercedes-Benz recalls various GLE and GLS class vehicles - ConsumerAffairs

Wed, 11 May 2022
OFAC issues 4 Russia-related GLs & NRC to suspend Russia nuclear GLs - EU Sanctions

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 72 (M)
Shares Float 1 (M)
% Held by Insiders 40.1 (%)
% Held by Institutions 56 (%)
Shares Short 189 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -107.59
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -164.75
Profit Margin (%) 0
Operating Margin (%) -770
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 686.9
Gross Profit (p.s.) 0.26
Sales Per Share 0.14
EBITDA (p.s.) -1.08
Qtrly Earnings Growth 0
Operating Cash Flow -30 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.05
PEG Ratio 0
Price to Book value -0.04
Price to Sales 34.41
Price to Cash Flow -12.04

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.